Ignite Creation Date:
2025-12-24 @ 4:57 PM
Ignite Modification Date:
2026-02-25 @ 4:57 PM
Study NCT ID:
NCT02263950
Status:
UNKNOWN
Last Update Posted:
2015-09-07
First Post:
2014-10-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1/2a Study of LON002 in Subjects With Advanced Solid Tumours
Sponsor:
LondonPharma Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LON002-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None